AMC Earnings Day: Institutions Pile In as Shorts Keep Retreating

AMC reports today with a striking ownership story developing in the background: three separate Schedule 13G filings landed in the past week alone, with Peconic Partners disclosing a fresh 6.3% stake (56.4 million shares), Vanguard Capital Management filing a new 5.19% position, and BlackRock lifting its holding to 7.6% from 5.5% previously. All three filings are passive, and as ORTEX's disclosure note cautions, these stakes are as last disclosed around the 5% threshold and holders can exit without a further filing. Even so, the clustering of large-holder disclosures on the eve of an earnings print is unusual for a stock that only recently escaped deep distress.

Short positioning has continued to ease since the October 28 article noted the initial pullback. Short interest now sits at 9.1% of the free float, roughly 46.9 million shares, down another 6.2% on the week and 14.6% over the past month after peaking above 54 million shares in late September. Availability remains extraordinarily loose at 848%, meaning there are more than eight shares available to lend for every one already borrowed, and borrowing costs hold at a negligible 0.42%. Nothing in the lending market suggests short sellers are under pressure; they are simply stepping away voluntarily ahead of the print.

Options traders are leaning call-heavy rather than defensive. The put/call ratio of 0.265 sits just below its 20-day average of 0.273, well off the 52-week high of 0.356 hit in early October. This is not a market hedging against a bad quarter. The stock itself has added 9.7% over the past week and 18.4% over the past month, now trading at $3.28, comfortably above the mean analyst price target of $3.37. The analyst community remains cautious: Citigroup holds a Sell with a $2.20 target, while Macquarie and B. Riley sit at Neutral, and only Wedbush and Benchmark carry constructive ratings, with Wedbush's $4.00 target the most bullish on the Street.

The bull and bear cases remain sharply drawn. Bulls point to projected EBITDA growth of 53% in 2026 and a film slate they argue can drive attendance recovery, alongside net leverage improving toward 7x by year-end. Bears counter that AMC's own adjusted EBITDA guidance still implies a $7 million loss on $955 million of revenue, that attendance headwinds compound against a heavy fixed-cost base, and that quantitative models flag the stock as expensive relative to peers. The last four earnings prints produced a 1-day move of plus 13.4%, minus 6.3%, plus 2.4%, and plus 3.5% respectively: directionally unpredictable, but the five-day reaction has been the more volatile window, ranging from minus 15.8% to plus 29.4%.

Today's print is therefore less a test of whether AMC is recovering and more a test of whether the Q3 numbers can justify a stock that has nearly doubled year-to-date and now trades above most of the analyst targets that have been raised into it.